Noradrenaline metabolism (None established; sometimes abbreviated as "NE metabolism" in literature, but not a standard target abbreviation.)

Noradrenaline metabolism refers collectively to the enzymatic pathways responsible for synthesizing and degrading noradrenaline—a key neurotransmitter and hormone involved in regulating cardiovascular function and stress responses. Synthesis begins from tyrosine via several steps involving tyrosine hydroxylase and dopamine β-hydroxylase; degradation primarily occurs through monoamine oxidase A/B and catechol-O-methyltransferase into metabolites like vanillylmandelic acid. These processes are essential for terminating neurotransmitter action at synapses and maintaining homeostasis within the autonomic nervous system. Disruption can contribute to various diseases including hypertension, depression, neurodegeneration, or endocrine tumors like pheochromocytoma[1][2][7].

Other names

Norepinephrine metabolismCatecholamine catabolism (broader)NE metabolism

Inhibition of enzymatic degradation increases synaptic norepinephrine levels (MAO/COMT inhibitors) Blockade/inhibition of reuptake prolongs norepinephrine action at synapses Indirect agonists increase release or block uptake/reuptake mechanisms